Works matching IS 20457634 AND DT 2021 AND VI 10 AND IP 4


Results: 26
    1
    2
    3
    4
    5
    6
    7

    R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 4, p. 1314, doi. 10.1002/cam4.3730
    By:
    • Sancho, Juan‐Manuel;
    • Fernández‐Alvarez, Rubén;
    • Gual‐Capllonch, Francisco;
    • González‐García, Esther;
    • Grande, Carlos;
    • Gutiérrez, Norma;
    • Peñarrubia, María‐Jesús;
    • Batlle‐López, Ana;
    • González‐Barca, Eva;
    • Guinea, José‐María;
    • Gimeno, Eva;
    • Peñalver, Francisco‐Javier;
    • Fuertes, Miguel;
    • Bastos, Mariana;
    • Hernández‐Rivas, José‐Ángel;
    • Moraleda, José‐María;
    • García, Olga;
    • Sorigué, Marc;
    • Martin, Alejandro
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 4, p. 1212, doi. 10.1002/cam4.3717
    By:
    • Gan, Chun Loo;
    • Dudani, Shaan;
    • Wells, J. Connor;
    • Donskov, Frede;
    • Pal, Sumanta K.;
    • Dizman, Nazli;
    • Rathi, Nityam;
    • Beuselinck, Benoit;
    • Yan, Flora;
    • Lalani, Aly‐Khan A.;
    • Hansen, Aaron;
    • Szabados, Bernadett;
    • Velasco, Guillermo;
    • Tran, Ben;
    • Lee, Jae Lyun;
    • Vaishampayan, Ulka N.;
    • Bjarnason, Georg A.;
    • Subasri, Mathushan;
    • Choueiri, Toni K.;
    • Heng, Daniel Y. C.
    Publication type:
    Article
    26

    Issue Information.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 4, p. 1181, doi. 10.1002/cam4.3156
    Publication type:
    Article